Results 221 to 230 of about 113,609 (263)

CD19

1998
Tak W. Mak, Josef Penninger, John Roder, Janet Rossant, Mary Saunders   +4 more
openaire   +1 more source

CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells

Cancers, 2020
Mingyao Liu, Wenzheng Jiang, Iqra Ajmal   +2 more
exaly  

Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease

British Journal of Haematology, 2021
Elena Zerkalenkova, Alexander Popov, Ekaterina Mikhailova   +2 more
exaly  

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

Blood, 2010
James Kochenderfer, Steven Rosenberg, Zhiya Yu   +2 more
exaly  

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Blood, 2012
James Kochenderfer, Steven A Feldman, Mark E Dudley   +2 more
exaly  

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies

Journal of Cellular and Molecular Medicine, 2016
Oliver Ottmann, Torsten Tõnn, Winfried S Wels   +2 more
exaly  

Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19+ tumors

Molecular Oncology, 2017
Christene A Huang, Zhirui Wang, Zhaohui Wang   +2 more
exaly  

CD19 regulates B lymphocyte responses to transmembrane signals

Seminars in Immunology, 1998
Manabu Fujimoto, Jonathan Poe, T F Tedder   +2 more
exaly  

CD19 variants

2019
LOBB ROY, RENNERT PAUL, HACKEL BENJAMIN, KLESMITH JUSTIN   +3 more
openaire   +4 more sources

CD19

2016
openaire   +1 more source